Core Viewpoint - The Gross Law Firm is notifying shareholders of Telix Pharmaceuticals Ltd. about a class action lawsuit due to alleged misleading statements regarding the company's progress and operations [1][3]. Summary by Sections Class Action Details - The class period for the lawsuit is from February 21, 2025, to August 28, 2025 [3]. - Allegations include that Telix overstated its progress on prostate cancer therapeutic candidates and the quality of its supply chain and partners [3]. Shareholder Actions - Shareholders are encouraged to register for the class action by January 9, 2026, to potentially become lead plaintiffs [4]. - Registration allows shareholders to receive updates through a portfolio monitoring software [4]. Law Firm Background - The Gross Law Firm aims to protect investors' rights against deceit and fraud, emphasizing responsible business practices [5].
Investors in Telix Pharmaceuticals Ltd. Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX